Clinical Trial Update: Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating TRC101 for metabolic acidosis in chronic kidney disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Metabolic Acidosis

Drugs mentioned

• TRC101 (TRC101)

Snippet

Sponsor: Tricida, Inc. | Conditions: Metabolic Acidosis | Phase 3 | Status: COMPLETED | Results posted: 2021-04-26